Embedded Files
게시일: 2018. 10. 12 오후 1:53:47
What is the MIT $100K?
One competition - three independent contests - from October through May. Now in its 30th year, the MIT $100K Entrepreneurship Competition has brought together students and researchers from across MIT and Greater Boston to launch their talent, ideas, and technology into leading companies.
The competition runs as series of distinct, increasingly intensive contests: Pitch, Accelerate, and Launch.
Each contest focuses on developing specific founder skills. For semi-finalists in Accelerate and Pitch, the MIT $100K brings together a network of resources, including mentorship from venture capitalists, serial entrepreneurs, corporate executives, and attorneys; media exposure; prototyping funds; business plan feedback; and discounted services. More than $300K in non-dilutive funding is awarded to accelerate these new ventures.
https://www.mit100k.org/#about
Department career expo
This Biological Engineering Career Expo takes place in the Samberg Conference Center at MIT in two adjoining rooms to provide maximum flexibility for combined recruiting of undergraduate and PhD-level candidates. One room accommodates tables for company displays and is the primary venue for recruiting BS-level students.
The other room is to have company tables and PhD research posters. PhD-level candidates will present posters from 2pm – 4:45 pm. MIT BE faculty are invited to attend the poster session. BS-level candidates will be invited to visit the displays 3 – 4:45 pm. This arrangement allows maximum flexibility for companies recruiting at both BS and PhD levels, especially with multiple recruiters. The event can accommodate up to 6 recruiters per company.
*Note: Resumes submitted by Friday 10/12 at midnight will be compiled and sent to companies. Printed nametags will also be made available for those who register before this deadline.
https://bioengcareerexpo.mit.edu/
Universities fund off-the-wall research from their own pockets
The competition to secure funding can deter applicants from submitting radical research proposals, despite their potential for dramatic advance. At University College London (UCL), we have been running a programme for ten years that bypasses conventional funding mechanisms, using our own resources to open up new and unpredictable lines of enquiry. A grant-application system such as that used today would probably have denied support to many of the twentieth-century scientists who fundamentally changed the ways we think. For example, molecular biologist Oswald Avery and his colleagues disproved the widely held belief that the genetic molecule was a protein (O. T. Avery et al. J. Exp. Med. 79, 137–158; 1944). UCL took its lead from British Petroleum’s Venture Research Unit (1980–93), which awarded funding to a handful of applicants with radical ideas — simply on the basis of face-to-face discussion. Despite vetoes by peer reviewers, the unit supported academics such as Ken Seddon, who became the United Kingdom’s most cited chemist for his work on ionic liquids, and Steve Davies, who set up a company to further his research into molecular architecture and chiral selection. The company sold in 2000 for £316 million (then about US$200 million) — some 15 times the unit’s total outlay on venture research. Universities should follow UCL’s lead and use their own resources to set up similar initiatives.
Page updated
Report abuse